Jorge DiMartino - Dec 12, 2023 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Medical Officer & VP
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Stock symbol
KRON
Transactions as of
Dec 12, 2023
Transactions value $
-$22,664
Form type
4
Date filed
12/13/2023, 04:09 PM
Previous filing
Jul 7, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Sale -$22.7K -17.4K -5.04% $1.31 327K Dec 12, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
F2 The weighted average sale price for the transaction reported was $1.305, and the range of prices were between $1.215 to $1.41. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.